| 89K |
| $675K |
| 0.0% |
| 2.208% |
| 0.00% |
| 4 | BlackRock, Inc. | 84K | $637K | 0.0% | 2.083% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 43K | $326K | -6.0% | 1.067% | 0.00% |
| 6 | HighTower Advisors, LLC | 40K | $300K | +0.0% | 0.982% | 0.00% |
| 7 | TWO SIGMA INVESTMENTS, LP | 40K | $298K | -20.2% | 0.976% | 0.00% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 27K | $204K | -1.5% | 0.669% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 24K | $182K | +0.7% | 0.595% | 0.00% |
| 10 | Birchview Capital, LP | 23K | $170K | 0.0% | 0.557% | 0.08% |
| 11 | STATE STREET CORP | 20K | $153K | 0.0% | 0.501% | 0.00% |
| 12 | UBS Group AG | 8K | $59K | -71.5% | 0.194% | 0.00% |
| 13 | GROUP ONE TRADING LLC | 4K | $33K | -1.9% | 0.109% | 0.00% |
| 14 | Vanguard Global Advisers, LLC | 1K | $11K | 0.0% | 0.035% | 0.00% |
| 15 | Tower Research Capital LLC (TRC) | 1K | $8K | +235.2% | 0.028% | 0.00% |
| 16 | Axiom Investment Management LLC | 704 | $5K | 0.0% | 0.017% | 0.00% |
| 17 | MORGAN STANLEY | 487 | $4K | -0.2% | 0.012% | 0.00% |
| 18 | HARBOUR INVESTMENTS, INC. | 200 | $2K | 0.0% | 0.005% | 0.00% |
| 19 | NATIONAL BANK OF CANADA /FI/ | 193 | $1K | 0.0% | 0.005% | 0.00% |
| 20 | OSAIC HOLDINGS, INC. | 182 | $1K | +1.1% | 0.005% | 0.00% |
| 21 | Nova Financial LLC | 160 | $1K | 0.0% | 0.004% | 0.00% |
| 22 | SBI Securities Co., Ltd. | 152 | $1K | 0.0% | 0.004% | 0.00% |
| 23 | ROYAL BANK OF CANADA | 138 | $1K | +0.7% | 0.003% | 0.00% |
| 24 | ACADIAN ASSET MANAGEMENT LLC | 106K | $795 | 0.0% | 2.608% | 0.00% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 46 | $347 | -8.0% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KYNB — a direct measure of their conviction.
| $9M |
| 47% |
| Q4 2024 | 69 | 2.8% | 1.28% | 145.63 pp | $17M | 99% |
| Q3 2024 | 71 | — | 146.91% | — | $1.48B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
1 institutions opened new positions in KYNB during Q2 2026, while 5 fully exited. 24 added to existing positions and 2 trimmed.
KYNB institutional ownership fell by 0.89 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 96.1% of all reported 13F value in KYNB, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), CNSY (4.8%), NXTS (3.3%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.